Dr. Ordobazari received her MD from Shahid Beheshti University in Tehran, Iran. She completed a residency in Anatomic and Clinical Pathology at the Medical College of Wisconsin. She went on to complete a Cytopathology Fellowship at the University of Florida College of Medicine, followed by a Breast and Gynecologic Pathology Fellowship at the University of Miami Miller School of Medicine. Dr. Ordobazari joins us from Women's Care Florida Laboratory. Dr. Ordobazari’s clinical focus is gynecological pathology and cytopathology. Her research interests are focused on the diagnosis and management of precancerous and malignant lesions of the uterine cervix.
Education & Training
- University of Miami/Jackson Memorial/Sylvester Cancer Center - GYN/Breast Pathology
- University of Florida College of Medicine - Cytopathology
- Medical College of Wisconsin - Anatomical and Clinical Pathology
- Shahid Beheshti University - MD
- Spasić S, Ordobazari A, Nadji M, Huang M, Pinto A. Papillary Squamous Cell Carcinoma of the Uterine Cervix: Biopsy Samples Frequently Underrepresent the Presence of Stromal Invasion. Int J Gynecol Pathol. 2021 Jul.40(4):408-412. Pubmedid: 33323853.
- Vosoughi A, Ordobazari A, Lora Gonzalez MA, Guido LP, Skiba M, Campuzano-Zuluaga G, Kryvenko ON, Gomez-Fernandez C, Garcia-Buitrago M, Jorda M. The Paris System "atypical urothelial cells" category: can the current criteria be improved?. J Am Soc Cytopathol. 2021 Jan.10(1):3-8. Pubmedid: 32732113.
- Vosoughi A, Smith PT, Zeitouni JA, Sodeman MSc GM, Jorda M, Gomez-Fernandez C, Garcia-Buitrago M, Ordobazari A, Petito CK, Chapman JR, Campuzano-Zuluaga G, Rosenberg AE, Kryvenko ON. Frozen section evaluation via dynamic real-time nonrobotic telepathology system in a university cancer center by resident/faculty cooperation team. Hum Pathol. 2018 Aug.78:144-150. Pubmedid: 29723604.
- Harrington AM, Schelling LA, Ordobazari A, Olteanu H, Hosking PR, Kroft SH. Immunophenotypes of Chronic Myelomonocytic Leukemia (CMML) Subtypes by Flow Cytometry: A Comparison of CMML-1 vs CMML-2, Myeloproliferative vs Dysplastic, De Novo vs Therapy-Related, and CMML-Specific Cytogenetic Risk Subtypes. Am J Clin Pathol. 2016 Aug.146(2):170-181. Pubmedid: 27413139.
Patient CommentsOverall Satisfaction0
0 patients rated this provider
The Provider Rating is an average of all responses to specific care provider-related questions from our nationally-recognized Press Ganey Patient Satisfaction Survey. Responses are measured on a scale of 1 to 5 with 5 being the best score.
Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.Learn more about our patient satisfaction survey
Comments are gathered from specific care provider-related questions from our Patient Satisfaction Survey . The comments are submitted by patients and reflect their views and opinions. Patients are de-identified for confidentiality and patient privacy.
We post both positive and negative comments from the surveys. We do not post comments that are libelous, slanderous, profane, irrelevant or otherwise inappropriate or may risk the privacy of our patients. A “[…]” in the comments below indicates de-identified patient information or comments that are unrelated to the patient’s experience with the visit to the provider, such as comments related to another provider, about the survey itself, or otherwise completely off-topic.
Not all providers will have a star rating or comments. In order to ensure accuracy of our ratings, we only display ratings for providers who have a minimum of 30 completed from the previous 12 months.
Provider Ratings and comments are gathered from our nationally-recognized Press Ganey Patient Satisfaction Survey. If a provider does not have ratings or comments listed it can be for several reasons, including:
- The provider has not yet received the minimum number of patient satisfaction surveys to be eligible for display. We require a minimum of 30 surveys before we post results to ensure that the rating is statistically reliable and a true reflection of patient satisfaction.
- He or she may be a researcher or other type of provider that does not see patients.
- The provider practices in a specialty or office that does not use the specified surveys currently used for these ratings.